Lipid Formulations of Amphotericin B
- 1 October 1995
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 13 (4), 207-218
- https://doi.org/10.2165/00002018-199513040-00001
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Anaphylactic reactions to liposomal amphotericinThe Lancet, 1994
- Amphotericin B-induced nephrogenic diabetes insipidus: resolution with its liposomal counterpart.1994
- Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.1993
- Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDSAIDS, 1993
- Successful Treatment of Fungal Infections in Neutropenic Patients with Liposomal Amphotericin (AmBisome)—A Report on 40 Cases from a Single CentreLeukemia & Lymphoma, 1992
- Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteersAntimicrobial Agents and Chemotherapy, 1991
- Overview of liposomesJournal of Antimicrobial Chemotherapy, 1991
- Overview of the treatment of disseminated fungal infectionsJournal of Antimicrobial Chemotherapy, 1991
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- Incidence of polyene-resistant yeasts recovered from clinical specimensAntimicrobial Agents and Chemotherapy, 1980